Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy

BACKGROUND: Current treatment options for stage III non-small cell lung cancer (NSCLC) consist of different combinations of chemotherapy, surgery, radiotherapy and immunotherapy. Treatment choices are highly individual decisions, in which adverse events (AEs) are relevant for decision-making. This s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:ERJ Open Res
Main Authors: Iseli, Thomas, Berghmans, Thierry, Glatzer, Markus, Rittmeyer, Achim, Massard, Gilbert, Durieux, Valérie, Buchsbaum, Thomas, Putora, Paul Martin
Formato: Artigo
Idioma:Inglês
Publicado: European Respiratory Society 2020
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7487347/
https://ncbi.nlm.nih.gov/pubmed/32963993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00010-2020
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares